Urriellu Ventures
Overview
Early-stage business assistance in biotechnology and health technology.
Deals · 12mo
1
Links
Stage focus
Geographic focus
Sector focus
Investment portfolio
- Pragmatech
Participated · Equity · Dec 2025
Founded in 2021 in Oviedo, Pragmatech develops iAST®, an AI-powered clinical decision-support tool that recommends the most appropriate antibiotic treatment and has secured CE marking as a medical device. The software has been clinically validated to cut prescribing errors and suggest therapies with lower resistance potential, addressing both patient outcomes and antimicrobial stewardship. Pragmatech operates on a B2B model, selling directly to hospitals and healthcare systems. With fresh capital in hand, the team plans a broad commercial rollout of iAST® while continuing to refine the algorithm to keep pace with evolving resistance patterns. Co-CEOs Javier Fernández and Pablo Valledor stress that the goal is to embed safe, effective AI into routine infectious-disease management. The company positions itself as a driver of digital transformation in microbiology and pharmacology. The recent €650k raise provides runway for sales expansion and further product development, but no revenue or user metrics have yet been disclosed.
- Imageryst
Participated · Equity · Mar 2024
Imageryst is a SaaS platform that uses artificial intelligence and remote sensing to extract geospatial information from satellite images via an intuitive user interface and a powerful API. The product makes geospatial data accessible to users of all technical levels and can identify elements such as buildings, roads, parcels and vegetation. Its solutions have been adopted in sectors like renewable energy for use cases including grid monitoring, risk prevention, solar-panel siting, construction monitoring, and maintenance of solar and wind farms. Clients include energy companies such as Iberdrola and technology/innovation firms like Solum. The company, based in Oviedo, is a little over one year old and has experienced promising growth. Imageryst plans to use its recent financing to strengthen its national position, expand into international markets, and explore additional sector use cases.